Clinical Trial Update: To Test The Relative Bioavailability Of PF-04191834 When Dosed As An Immediate Release Tablet Compared With Solution Following Single And Multiple Dosing

View source ↗

Summary

Pfizer completed a pharmacokinetic study comparing an immediate-release tablet of PF-04191834 to a solution to determine relative bioavailability after single a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PF-04191834

Snippet

Sponsor: Pfizer | Conditions: Asthma | Status: COMPLETED